Cargando…

Recognition of BRAF by CDC37 and Re-Evaluation of the Activation Mechanism for the Class 2 BRAF-L597R Mutant

The kinome specific co-chaperone, CDC37 (cell division cycle 37), is responsible for delivering BRAF (B-Rapidly Accelerated Fibrosarcoma) to the Hsp90 (heat shock protein 90) complex, where it is then translocated to the RAS (protooncogene product p21) complex at the plasma membrane for RAS mediated...

Descripción completa

Detalles Bibliográficos
Autores principales: Bjorklund, Dennis M., Morgan, R. Marc L., Oberoi, Jasmeen, Day, Katie L. I. M., Galliou, Panagiota A., Prodromou, Chrisostomos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313131/
https://www.ncbi.nlm.nih.gov/pubmed/35883461
http://dx.doi.org/10.3390/biom12070905
_version_ 1784754003979010048
author Bjorklund, Dennis M.
Morgan, R. Marc L.
Oberoi, Jasmeen
Day, Katie L. I. M.
Galliou, Panagiota A.
Prodromou, Chrisostomos
author_facet Bjorklund, Dennis M.
Morgan, R. Marc L.
Oberoi, Jasmeen
Day, Katie L. I. M.
Galliou, Panagiota A.
Prodromou, Chrisostomos
author_sort Bjorklund, Dennis M.
collection PubMed
description The kinome specific co-chaperone, CDC37 (cell division cycle 37), is responsible for delivering BRAF (B-Rapidly Accelerated Fibrosarcoma) to the Hsp90 (heat shock protein 90) complex, where it is then translocated to the RAS (protooncogene product p21) complex at the plasma membrane for RAS mediated dimerization and subsequent activation. We identify a bipartite interaction between CDC37 and BRAF and delimitate the essential structural elements of CDC37 involved in BRAF recognition. We find an extended and conserved CDC37 motif, (20)HPNID---SL--W(31), responsible for recognizing the C-lobe of BRAF kinase domain, while the c-terminal domain of CDC37 is responsible for the second of the bipartite interaction with BRAF. We show that dimerization of BRAF, independent of nucleotide binding, can act as a potent signal that prevents CDC37 recognition and discuss the implications of mutations in BRAF and the consequences on signaling in a clinical setting, particularly for class 2 BRAF mutations.
format Online
Article
Text
id pubmed-9313131
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93131312022-07-26 Recognition of BRAF by CDC37 and Re-Evaluation of the Activation Mechanism for the Class 2 BRAF-L597R Mutant Bjorklund, Dennis M. Morgan, R. Marc L. Oberoi, Jasmeen Day, Katie L. I. M. Galliou, Panagiota A. Prodromou, Chrisostomos Biomolecules Article The kinome specific co-chaperone, CDC37 (cell division cycle 37), is responsible for delivering BRAF (B-Rapidly Accelerated Fibrosarcoma) to the Hsp90 (heat shock protein 90) complex, where it is then translocated to the RAS (protooncogene product p21) complex at the plasma membrane for RAS mediated dimerization and subsequent activation. We identify a bipartite interaction between CDC37 and BRAF and delimitate the essential structural elements of CDC37 involved in BRAF recognition. We find an extended and conserved CDC37 motif, (20)HPNID---SL--W(31), responsible for recognizing the C-lobe of BRAF kinase domain, while the c-terminal domain of CDC37 is responsible for the second of the bipartite interaction with BRAF. We show that dimerization of BRAF, independent of nucleotide binding, can act as a potent signal that prevents CDC37 recognition and discuss the implications of mutations in BRAF and the consequences on signaling in a clinical setting, particularly for class 2 BRAF mutations. MDPI 2022-06-28 /pmc/articles/PMC9313131/ /pubmed/35883461 http://dx.doi.org/10.3390/biom12070905 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bjorklund, Dennis M.
Morgan, R. Marc L.
Oberoi, Jasmeen
Day, Katie L. I. M.
Galliou, Panagiota A.
Prodromou, Chrisostomos
Recognition of BRAF by CDC37 and Re-Evaluation of the Activation Mechanism for the Class 2 BRAF-L597R Mutant
title Recognition of BRAF by CDC37 and Re-Evaluation of the Activation Mechanism for the Class 2 BRAF-L597R Mutant
title_full Recognition of BRAF by CDC37 and Re-Evaluation of the Activation Mechanism for the Class 2 BRAF-L597R Mutant
title_fullStr Recognition of BRAF by CDC37 and Re-Evaluation of the Activation Mechanism for the Class 2 BRAF-L597R Mutant
title_full_unstemmed Recognition of BRAF by CDC37 and Re-Evaluation of the Activation Mechanism for the Class 2 BRAF-L597R Mutant
title_short Recognition of BRAF by CDC37 and Re-Evaluation of the Activation Mechanism for the Class 2 BRAF-L597R Mutant
title_sort recognition of braf by cdc37 and re-evaluation of the activation mechanism for the class 2 braf-l597r mutant
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313131/
https://www.ncbi.nlm.nih.gov/pubmed/35883461
http://dx.doi.org/10.3390/biom12070905
work_keys_str_mv AT bjorklunddennism recognitionofbrafbycdc37andreevaluationoftheactivationmechanismfortheclass2brafl597rmutant
AT morganrmarcl recognitionofbrafbycdc37andreevaluationoftheactivationmechanismfortheclass2brafl597rmutant
AT oberoijasmeen recognitionofbrafbycdc37andreevaluationoftheactivationmechanismfortheclass2brafl597rmutant
AT daykatielim recognitionofbrafbycdc37andreevaluationoftheactivationmechanismfortheclass2brafl597rmutant
AT gallioupanagiotaa recognitionofbrafbycdc37andreevaluationoftheactivationmechanismfortheclass2brafl597rmutant
AT prodromouchrisostomos recognitionofbrafbycdc37andreevaluationoftheactivationmechanismfortheclass2brafl597rmutant